Verona Pharma PLC ADR • VRNA

Capital at risk.

About Verona Pharma PLC ADR
Ticker
info
VRNA
Trading on
info
NASDAQ
ISIN
info
US9250501064
Industry
info
Biotechnology
Sector
info
Healthcare
CEO
info
Dr. David Scott Zaccardelli Pharm.D.
Headquarters
info
3 More London Riverside, London, undefined, United Kingdom, SE1 2RE
Employees
info
209
Website
info
veronapharma.com
Verona Pharma plc, a biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company offers Ohtuvayre, a dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that combines bronchodilator and non-steroidal anti-inflammatory effects for the maintenance treatment of chronic obstructive pulmonary disease, as well as cystic fibrosis and asthma. Verona Pharma plc was formerly known as Isis Resources plc and changed its name to Verona Pharma plc in September 2006. The company was incorporated in 2005 and is based in London, the United Kingdom. As of October 7, 2025, Verona Pharma plc operates as a subsidiary of Merck Sharp & Dohme LLC.
Metrics
BasicAdvanced
Market cap
info
$9.09B
P/E ratio
info
-
EPS
info
-$1.04
Dividend Yield
info
0.00%
Beta
info
0.05
Forward P/E ratio
info
35.34
EBIDTA
info
$-52.7M
Ex dividend date
info
-
Price & volume
Market cap
info
$9.09B
Average daily volume
info
0.8M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
35.34
PEG ratio
info
0
Trailing P/E
info
0
Price to sales
info
40.98
Price to book
info
33.01
Earnings
EPS
info
-$1.04
EPS estimate (current quarter)
info
$0.11
EPS estimate (next quarter)
info
$0.29
EBITDA
info
$-52.7M
Revenues (TTM)
info
$222M
Revenues per share (TTM)
info
$2.65
Technicals
Beta
info
0.05
52-week High
info
$106.93
52-week Low
info
$34.51
50-day moving average
info
$105.95
200-day moving average
info
$79.84
Short ratio
info
1.56
Short %
info
2.44%
Management effectiveness
ROE (TTM)
info
-36.36%
ROA (TTM)
info
-6.68%
Profit margin
info
-36.63%
Gross profit margin
info
$211M
Operating margin
info
12.90%
Growth
Quarterly earnings growth (YoY)
info
0.00%
Quarterly revenue growth (YoY)
info
0.00%
Share stats
Outstanding Shares
info
85M
Float
info
565M
Insiders %
info
4.89%
Institutions %
info
92.23%
Analyst Insights & forecasts
info

100% Buy

0% Hold

0% Sell

Based on information from 10 analysts.

Average price target

info
$106.00
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-$0.56
-$0.50
-12.00%
Q3 • 24Missed
-$0.05
-$0.07
28.57%
Q4 • 24Beat
-$0.02
-$0.03
38.46%
Q1 • 25Beat
$0.06
$0.03
94.14%
Q2 • 25Beat
-
$0.14
-100.00%
Q3 • 25Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$59M
$-12.6M
-21.40%
Q1 • 25
$75.1M
$8.7M
11.56%
Q2 • 25
27.30%
-168.75%
-154.01%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$526M
$299M
56.92%
Q1 • 25
$573M
$295M
51.42%
Q2 • 25
8.92%
-1.58%
-9.65%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$-11.6M
$-0.5M
$13.5M
$-11.6M
Q1 • 25
$30.6M
$0M
$4.9M
$30.6M
Q2 • 25
-364.35%
-100.00%
-63.27%
-364.35%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Verona Pharma PLC ADR share?
Collapse

Verona Pharma PLC ADR shares are currently traded for undefined per share.

How many shares does Verona Pharma PLC ADR have?
Collapse

Verona Pharma PLC ADR currently has 85M shares.

Does Verona Pharma PLC ADR pay dividends?
Collapse

No, Verona Pharma PLC ADR doesn't pay dividends.

What is Verona Pharma PLC ADR 52 week high?
Collapse

Verona Pharma PLC ADR 52 week high is $106.93.

What is Verona Pharma PLC ADR 52 week low?
Collapse

Verona Pharma PLC ADR 52 week low is $34.51.

What is the 200-day moving average of Verona Pharma PLC ADR?
Collapse

Verona Pharma PLC ADR 200-day moving average is $79.84.

Who is Verona Pharma PLC ADR CEO?
Collapse

The CEO of Verona Pharma PLC ADR is Dr. David Scott Zaccardelli Pharm.D..

How many employees Verona Pharma PLC ADR has?
Collapse

Verona Pharma PLC ADR has 209 employees.

What is the market cap of Verona Pharma PLC ADR?
Collapse

The market cap of Verona Pharma PLC ADR is $9.09B.

What is the P/E of Verona Pharma PLC ADR?
Collapse

The current P/E of Verona Pharma PLC ADR is null.

What is the EPS of Verona Pharma PLC ADR?
Collapse

The EPS of Verona Pharma PLC ADR is -$1.04.

What is the PEG Ratio of Verona Pharma PLC ADR?
Collapse

The PEG Ratio of Verona Pharma PLC ADR is 0.

What do analysts say about Verona Pharma PLC ADR?
Collapse

According to the analysts Verona Pharma PLC ADR is considered a buy.